---
title: "SPRO.US (SPRO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SPRO.US/news.md"
symbol: "SPRO.US"
name: "SPRO.US"
parent: "https://longbridge.com/en/quote/SPRO.US.md"
datetime: "2026-06-19T12:05:26.264Z"
locales:
  - [en](https://longbridge.com/en/quote/SPRO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SPRO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SPRO.US/news.md)
---

# SPRO.US (SPRO.US) — Related News

### [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://longbridge.com/en/news/290197223.md)
*2026-06-18T12:06:41.000Z*
> In Thursday's pre-market session, several healthcare stocks saw significant movement. Aditxt surged 247.7% to $0.02, whi

### [Biggest stock movers Thursday: INTC, RUM, SPRO and more](https://longbridge.com/en/news/290180432.md)
*2026-06-18T10:21:38.000Z*
> Stock futures rose modestly as the Fed signaled potential year-end rate hikes. Key movers included Rumble (+17%) after a

### [Smith & Wesson Stock Shoots Higher After Q4 Earnings — Here's Why](https://longbridge.com/en/news/290106373.md)
*2026-06-17T20:31:24.000Z*
> Smith & Wesson Brands (SWBI) reported Q4 earnings that significantly beat analyst estimates, with EPS of $0.36 versus $0

### [U.S. stock night market volatility: Spero surged 27.49% in after-hours trading! Oral antibiotics approved, GSK backing ignites funding](https://longbridge.com/en/news/290138488.md)
*2026-06-18T04:06:37.000Z*
> Spero Therap rose 27.49% in after-hours trading; Elicio Therapeutics fell 15.07% in after-hours trading, with a trading 

### [GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs](https://longbridge.com/en/news/290086876.md)
*2026-06-17T17:29:25.000Z*
> The FDA has approved Utebzi (tebipenem pivoxil hydrobromide), the first oral carbapenem antibiotic for complicated urina

### [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://longbridge.com/en/news/290085511.md)
*2026-06-17T17:06:34.000Z*
> During Wednesday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Icec

### [Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) | SPRO Stock News](https://longbridge.com/en/news/290082797.md)
*2026-06-17T08:36:00.000Z*
> The FDA has approved Utebzi (tebipenem pivoxil), the first and only oral carbapenem antibiotic, for treating complicated